144 results on '"Zurko, Joanna"'
Search Results
2. Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
3. ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma
4. Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL
5. Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics
6. Association of a Gamified Journal Club on Internal Medicine Residents’ Engagement and Critical Appraisal Skills
7. Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma
8. Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection.
9. Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A Cost-Effectiveness Analysis.
10. Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-Cell Lymphomas Treated with Chimeric Antigen Receptor T-Cell (CART) Therapy
11. Outcomes of Relapsed Refractory Double Hit Lymphoma: A Multicenter Observational Cohort
12. Double Hit/Double Expressor Lymphomas: A Multicenter Analysis of Survival Outcomes with CD19-Directed CAR T-Cell Therapy
13. Consensus Cachexia Criteria Are Independently Linked to Progression Free and Overall Survival in Multi-Site Analysis of Patients with Aggressive B-Cell Lymphomas Treated with CAR T-Cell Therapy
14. Single Cell Cytokine Analyses of Bispecific, Tandem, Anti-CD20, Anti-CD19 CAR T-Cells from Patients with Relapsed, Refractory B-Cell Malignancies
15. Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20 .19 CAR T‐cells
16. Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL
17. Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies
18. Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
19. Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome
20. 8 - Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) after Chimeric Antigen Receptor T-Cell Therapy Failure
21. Phase 1/2 Trial of Bispecific LV20.19 CAR T-Cells for Relapsed, Refractory B-Cell Non-Hodgkin Lymphoma
22. Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) after Chimeric Antigen Receptor T-Cell Therapy Failure
23. Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis
24. Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy
25. Phase 1/2 Trial of IL7/IL15-Expanded Bispecific LV20.19 CAR T-Cells for Relapsed, Refractory B-Cell Non-Hodgkin Lymphoma
26. Practice Patterns Pre-CART for Aggressive B-Cell Lymphomas: Patient Selection and Real World Salvage and Bridging Practices
27. Manufacturing Bispecific LV20.19 CAR T-Cells with IL-7 & IL-15 for a Shorter Duration Improves CAR T-Cell Immunophenotype While Maintaining Target Cell Dose
28. Bispecific LV20.19 CAR T-Cells Expanded in IL-7 and IL-15 Have Greater Polyfunctionality and Polyfunctional Strength Than CAR T-Cells Expanded in IL-2
29. Outcomes and Treatment Patterns in Patients with Aggressive B-Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy
30. Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?
31. Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells.
32. 205 - Single Cell Cytokine Analysis of LV20.19 CAR T-Cells Expanded in IL-2 Versus IL-7 and IL-15
33. Matched case control analysis of breast cancer specific factors impacting risk of developing SARS-Cov-2 infection.
34. PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response
35. Single Cell Cytokine Analysis of LV20.19 CAR T-Cells Expanded in IL-2 Versus IL-7 and IL-15
36. Clinical and Manufacturing Outcomes of LV20.19 CAR T-Cells Expanded in IL-2 Versus IL-7 and IL-15
37. Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma
38. Infectious Diseases Consultation Is Associated With Decreased Mortality in Enterococcal Bloodstream Infections
39. 11 - Phase 1/2 Trial of Bispecific LV20.19 CAR T-Cells for Relapsed, Refractory B-Cell Non-Hodgkin Lymphoma
40. The impact of structural factors on diagnostic delay in diffuse large B‐cell lymphoma
41. Outcomes of Patients with Limited-Stage Aggressive Large B-Cell Lymphoma with MYC Rearrangement with and without BCL2 and/or BCL6 Rearrangements: A Retrospective Analysis from 15 US Academic Centers
42. Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With Candidemia
43. 214 - Clinical and Manufacturing Outcomes of LV20.19 CAR T-Cells Expanded in IL-2 Versus IL-7 and IL-15
44. Delayed subspecialist referral in diffuse large B-cell lymphoma: Predictive factors and impact on disease status and mortality.
45. Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy
46. Echinocandin resistance among Candida isolates at an academic medical centre 2005–15: analysis of trends and outcomes
47. Infectious Disease Consultation Is Associated with Decreased Mortality with Enterococcal Bloodstream Infections
48. Immunohistochemical assessment of rat nerve isografts and immunosuppressed allografts
49. Improved Survival of R/R Double Hit/Triple Hit Lymphoma in the Era of CD19 Chimeric Antigen T Cell (CART) Therapy
50. Echinocandin resistance in Candida glabrata bloodstream infection 2009–2015 at a single institution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.